• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶2稳定SPARC相关模块化钙结合蛋白2以促进胆囊癌转移和干性

Histone Deacetylase 2 Stabilizes SPARC-related Modular Calcium Binding 2 to Promote Metastasis and Stemness in Gallbladder Cancer.

作者信息

Feng Ji, Zheng Xueyong

机构信息

Department of General Surgery, Sir Run Run Shaw Hospital (SRRSH), Affiliated with the Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, 310000, China.

出版信息

Curr Mol Med. 2025;25(1):56-68. doi: 10.2174/0115665240257970231013094101.

DOI:10.2174/0115665240257970231013094101
PMID:38173203
Abstract

BACKGROUND

We aimed to investigate the relationship between histone deacetylase 2 (HDAC2) and SPARC-related modular calcium binding 2 (SMOC2) and the role of SMOC2 in gallbladder cancer (GBC).

METHODS

The expression of HDAC2 and SMOC2 in GBC and normal cells was detected by quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR), which was also used to detect the mRNA stability of SMOC2. The combination between HDAC2 and SMOC2 was detected by Chromatin immunoprecipitation (ChIP) assay. After silencing and/or overexpressing HDAC2 and SMOC2, cell viability, migration, invasion, and stemness were respectively tested by the Cell Counting Kit-8 (CCK-8), cell scratch, transwell, and sphere-formation assay.

RESULTS

In GBC cells, HDAC2 and SMOC2 were highly expressed. HDAC2 combined with SMOC2 promoted mRNA stability of SMOC2. HDAC2 or SMOC2 overexpression promoted GBC cell metastasis and stemness. SMOC2 overexpression rescued the negative effects of silencing HDAC2 in GBC.

CONCLUSION

HDAC2 stabilizes SMOC2 to promote metastasis and stemness in gallbladder cancer.

摘要

背景

我们旨在研究组蛋白去乙酰化酶2(HDAC2)与富含半胱氨酸的酸性分泌蛋白相关的模块化钙结合蛋白2(SMOC2)之间的关系以及SMOC2在胆囊癌(GBC)中的作用。

方法

采用定量实时逆转录聚合酶链反应(qRT-PCR)检测HDAC2和SMOC2在GBC细胞和正常细胞中的表达,该方法还用于检测SMOC2的mRNA稳定性。通过染色质免疫沉淀(ChIP)分析检测HDAC2与SMOC2之间的结合。在沉默和/或过表达HDAC2和SMOC2后,分别通过细胞计数试剂盒-8(CCK-8)、细胞划痕、Transwell和球体形成试验检测细胞活力、迁移、侵袭和干性。

结果

在GBC细胞中,HDAC2和SMOC2高表达。HDAC2与SMOC2结合可促进SMOC2的mRNA稳定性。HDAC2或SMOC2过表达促进GBC细胞转移和干性。SMOC2过表达可挽救沉默HDAC2对GBC的负面影响。

结论

HDAC2使SMOC2稳定,从而促进胆囊癌的转移和干性。

相似文献

1
Histone Deacetylase 2 Stabilizes SPARC-related Modular Calcium Binding 2 to Promote Metastasis and Stemness in Gallbladder Cancer.组蛋白去乙酰化酶2稳定SPARC相关模块化钙结合蛋白2以促进胆囊癌转移和干性
Curr Mol Med. 2025;25(1):56-68. doi: 10.2174/0115665240257970231013094101.
2
TEAD4 promoted proliferation and metastasis of gallbladder cancer by regulation of TMPRSS4.TEAD4 通过调节 TMPRSS4 促进胆囊癌的增殖和转移。
Clin Exp Metastasis. 2025 Apr 11;42(3):22. doi: 10.1007/s10585-025-10339-0.
3
SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers.SMOC2,一种肠干细胞标志物,是一种独立的预后标志物,与结直肠癌患者的更好生存相关。
Sci Rep. 2020 Sep 3;10(1):14591. doi: 10.1038/s41598-020-71643-1.
4
LncRNA LINC01857 drives pancreatic adenocarcinoma progression via modulating miR-19a-3p/SMOC2.长链非编码 RNA LINC01857 通过调节 miR-19a-3p/SMOC2 驱动胰腺导管腺癌的进展。
Clinics (Sao Paulo). 2022 Jun 2;77:100047. doi: 10.1016/j.clinsp.2022.100047. eCollection 2022.
5
Effect of CLIC1 gene silencing on proliferation, migration, invasion and apoptosis of human gallbladder cancer cells.沉默 CLIC1 基因对人胆囊癌细胞增殖、迁移、侵袭和凋亡的影响。
J Cell Mol Med. 2018 May;22(5):2569-2579. doi: 10.1111/jcmm.13499. Epub 2018 Mar 8.
6
KLF5 silencing restrains proliferation, invasion, migration and angiogenesis of gallbladder carcinoma cells by transcriptional regulation of PDGFA.KLF5基因沉默通过对血小板衍生生长因子A(PDGFA)的转录调控来抑制胆囊癌细胞的增殖、侵袭、迁移和血管生成。
J Cancer Res Clin Oncol. 2024 Dec 20;151(1):11. doi: 10.1007/s00432-024-06059-9.
7
ACAP3 negatively regulated by HDAC2 inhibits the malignant development of papillary thyroid carcinoma cells.ACAP3 通过 HDAC2 负调控抑制甲状腺乳头状癌细胞的恶性发展。
Int J Biochem Cell Biol. 2024 Sep;174:106635. doi: 10.1016/j.biocel.2024.106635. Epub 2024 Aug 3.
8
miRNA-105-5p regulates the histone deacetylase HDAC2 through FOXG1 to affect the malignant biological behavior of triple-negative breast cancer cells.微小RNA-105-5p通过叉头框蛋白G1调控组蛋白去乙酰化酶HDAC2,从而影响三阴性乳腺癌细胞的恶性生物学行为。
Am J Med Sci. 2025 Apr;369(4):513-523. doi: 10.1016/j.amjms.2024.09.009. Epub 2024 Sep 21.
9
Histone deacetylase HDAC2 regulates microRNA-125a expression in neuroblastoma.组蛋白去乙酰化酶 HDAC2 调控神经母细胞瘤中 microRNA-125a 的表达。
Brain Behav. 2022 Feb;12(2):e2401. doi: 10.1002/brb3.2401. Epub 2022 Jan 21.
10
Prognostic significance of long non-coding RNA MALAT1 for predicting the recurrence and metastasis of gallbladder cancer and its effect on cell proliferation, migration, invasion, and apoptosis.长链非编码 RNA MALAT1 对预测胆囊癌复发转移的预后意义及其对细胞增殖、迁移、侵袭和凋亡的影响。
J Cell Biochem. 2018 Apr;119(4):3099-3110. doi: 10.1002/jcb.26451. Epub 2017 Dec 26.

本文引用的文献

1
Smoc1 and Smoc2 regulate bone formation as downstream molecules of Runx2.Smoc1 和 Smoc2 作为 Runx2 的下游分子调节骨形成。
Commun Biol. 2021 Oct 19;4(1):1199. doi: 10.1038/s42003-021-02717-7.
2
Roles of HDAC2, eIF5, and eIF6 in Lung Cancer Tumorigenesis.HDAC2、eIF5 和 eIF6 在肺癌发生中的作用。
Curr Med Sci. 2021 Aug;41(4):764-769. doi: 10.1007/s11596-021-2389-z. Epub 2021 Aug 17.
3
Histone deacetylase 2 selective inhibitors: A versatile therapeutic strategy as next generation drug target in cancer therapy.
组蛋白去乙酰化酶 2 选择性抑制剂:癌症治疗中下一代药物靶点的多功能治疗策略。
Pharmacol Res. 2021 Aug;170:105695. doi: 10.1016/j.phrs.2021.105695. Epub 2021 Jun 1.
4
HDAC2 interacts with microRNA-503-5p to regulate SGK1 in osteoarthritis.组蛋白去乙酰化酶 2 与 microRNA-503-5p 相互作用调节骨关节炎中的 SGK1。
Arthritis Res Ther. 2021 Mar 9;23(1):78. doi: 10.1186/s13075-020-02373-y.
5
HDAC2 inhibits EMT-mediated cancer metastasis by downregulating the long noncoding RNA H19 in colorectal cancer.组蛋白去乙酰化酶 2 通过下调结直肠癌中的长非编码 RNA H19 抑制 EMT 介导的癌症转移。
J Exp Clin Cancer Res. 2020 Dec 2;39(1):270. doi: 10.1186/s13046-020-01783-9.
6
HDAC2-mediated proliferation of trophoblast cells requires the miR-183/FOXA1/IL-8 signaling pathway.HDAC2 介导的滋养细胞增殖需要 miR-183/FOXA1/IL-8 信号通路。
J Cell Physiol. 2021 Apr;236(4):2544-2558. doi: 10.1002/jcp.30026. Epub 2020 Nov 8.
7
A SMOC2 variant inhibits BMP signaling by competitively binding to BMPR1B and causes growth plate defects.一个 SMOC2 变异体通过竞争性结合 BMPR1B 抑制 BMP 信号通路,导致生长板缺陷。
Bone. 2021 Jan;142:115686. doi: 10.1016/j.bone.2020.115686. Epub 2020 Oct 12.
8
Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance.SMOC2 表达下调在甲状腺乳头状癌中的表达及其预后意义。
Sci Rep. 2020 Mar 17;10(1):4853. doi: 10.1038/s41598-020-61828-z.
9
Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends.美洲的胆囊和肝外胆管癌:发病和死亡模式及趋势。
Int J Cancer. 2020 Aug 15;147(4):978-989. doi: 10.1002/ijc.32863. Epub 2020 Jan 21.
10
Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis.基于纳米医学的癌症转移免疫治疗。
Adv Mater. 2019 Dec;31(49):e1904156. doi: 10.1002/adma.201904156. Epub 2019 Sep 30.